This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Health product recall

pms-Clonazepam (2016-09-06)

Starting date:
September 6, 2016
Posting date:
September 20, 2016
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type II
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-60302

Affected Product

pms-Clonazepam

Reason

This lot of Clonazepam 1 mg may contain tablets of Terazosin-HCl 5 mg.

Depth of distribution

Canada: wholesalers, pharmacies

Affected products

pms-Clonazepam

DIN, NPN, DIN-HIM
DIN 02048728
Dosage form

Tablet

Strength

1 mg

Lot or serial number

499048

Companies
Recalling Firm
Pharmascience Inc.
100, 6111 Royalmount Avenue
Montreal
H4P 2T4
Quebec
CANADA
Marketing Authorization Holder
Pharmascience Inc.
100, 6111 Royalmount Avenue
Montreal
H4P 2T4
Quebec
CANADA